Microfluidic-based polypeptide-based helical fiber with circularly polarized luminescence and preparation method thereof
Patent Information
- Application Number
- CN202411277318.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-12
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-09-12
AI Technical Summary
[0007]但是,现有的开放小瓶体系中制备产生的螺旋纤维结构难以精确控制,不能满足相关的使用要求
[0026] Compared with the existing technology, the advantage of the present invention is that the present invention utilizes multiple hydrogen bonds between polypeptides and develops polypeptides with excellent luminescent properties based on the solute conformation restriction and solvent orderly diffusion mechanism of the microfluidic laminar flow chip. Base circularly polarized luminescent material, Circular dichroism and circular polarization spectroscopy tests show that the spiral fiber material obtained by the present invention has a mirror-symmetric signal; compared with the material obtained by stirring the traditional solution, the polypeptide-based spiral fiber produced in the microfluidic chip of the present invention not only has a better morphology Uniform and with larger g lum value, the luminescence asymmetry factor of L-Peptide/TBI and D-Peptide/TBI is ±1.9 × 10 -3 ; This method has certain universality and is suitable for the assembly of other macromolecules, including polymers, nucleic acids, and proteins.
Smart Images

Figure CN118932518A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of nanomaterials, and in particular to a polypeptide-based helical fiber with circularly polarized luminescence based on microfluidics and a preparation method thereof. Background Art
[0002] Helical structures are ubiquitous in nature, from the nanoscale DNA double helix and secondary protein structures to macroscopic patterns on nautilus shells and tendrils of climbing plants. The helical morphology is considered to be the most basic topological structure in natural structures. Artificial helical nanostructures with right-handed (P) or left-handed (M) helicity are of great significance for studying the origin of chirality and its potential applications in materials science, nonlinear optics, biological systems, chemical sensing, chiral selective catalysis, and chiral devices.
[0003] For supramolecular self-assembly systems, the reported preparation schemes for helical structures mainly include non-covalent interactions such as hydrogen bonding, π-π stacking and coordination bonds. Although single-component self-assembly is considered an effective method to obtain helical structures at the nanometer to micrometer scale, it has great limitations in the flexible modulation of supramolecular chirality. Environmental factors such as temperature, solvent or concentration are the preferred factors for controlling the properties of assemblies formed by single-component self-assembly. In contrast, multi-component assembly can control supramolecular chirality at different levels by introducing different components, and different components can synergize to make up for the shortcomings of a single material and enhance stability, and produce diverse chiral structures and soft materials in a precise and modular manner. In recent years, it has received increasing attention.
[0004] Amino acids are the basic units of peptides and proteins, and contain multiple amino and carboxylic acid functional groups that are easily modified. Due to their easy modification, abundant non-covalent binding sites, and inherent chirality, they are widely used in the construction of multi-component helical nanosystems, such as helical tubular aggregates, helical polymers, and small molecule helical assemblies.
[0005] Circularly polarized luminescence (CPL) materials have potential application prospects in optical sensors, three-dimensional displays, optoelectronic devices, spintronic devices, and information storage.
[0006] At present, one method of obtaining CPL materials is the self-assembly of chiral organic or inorganic luminescent materials, including organic small molecules, polymers and lanthanide complexes with chiral centers. To achieve this goal, chiral luminescent materials often require lengthy synthesis routes, and the emission characteristics of CPL materials are difficult to predict and control. On the other hand, multi-component self-assembly has been shown to be a good method for constructing CPL materials and improving the luminescence asymmetry factor (g lum) value. After multi-component self-assembly, the non-chiral luminophore is fixed in the chiral environment brought by the chiral fragment, and the chirality is allowed to transfer to the luminophore under the photoexcited state, which is expected to obtain high-performance CPL materials. Currently, CPL materials obtained by multi-component assembly are mainly carried out in an open vial system.
[0007] However, the spiral fiber structure produced in the existing open vial system is difficult to accurately control and cannot meet relevant usage requirements. Summary of the invention
[0008] One of the purposes of the present invention is to provide a method for preparing polypeptide-based helical fibers with circularly polarized luminescence to solve the above-mentioned problems.
[0009] In order to achieve the above object, the technical solution adopted by the present invention is as follows: a method for preparing a polypeptide-based helical fiber with circularly polarized luminescence based on microfluidics, the method comprising:
[0010] (1) First, prepare the DMSO (dimethyl sulfoxide) stock solution of L-peptide or D-peptide, the DMSO stock solution of TBI, and the NaOH aqueous solution respectively;
[0011] (2) Then, the DMSO mother solution of the L-peptide or D-peptide and the DMSO mother solution of TBI are flowed into the chip from the inner channel of the microfluidic chip, and the NaOH aqueous solution is flowed into the chip from the outer channel of the microfluidic chip, and then assembled in the microfluidic chip to obtain an assembly;
[0012] (3) Aging the assembly to obtain polypeptide-based helical fibers with circularly polarized luminescence.
[0013] The present invention uses a microfluidic chip to perform multi-component self-assembly to obtain a fiber material with AIE (Aggregation-Induced Emission) effect. Specifically, the present invention uses a chiral polypeptide and an achiral aggregation-induced emission molecule for co-assembly to achieve the construction of a circularly polarized luminescent material. The present invention uses a microfluidic device to perform multi-component self-assembly, which is a new strategy for preparing spiral fibers with circularly polarized luminescence.
[0014] As a preferred technical solution, in step (1), the amino acid sequences of the L-peptide and the D-peptide are GFFVLK or KLVFF.
[0015] In the above sequence, as is well known to those skilled in the art, G is glycine (Gly), F is phenylalanine (Phe), V is valine (Val), L is leucine (Leu), and K is lysine (Lys).
[0016] Among them, the lysine at the end of GFFVLK can adjust its isoelectric point by acid and base (hydrochloric acid-sodium hydroxide solution), which provides the possibility of constructing a multi-component assembly based on the strategy of hydrophilicity, hydrophobicity and electrostatic interaction. The L-peptide (L-Peptide) or (D-Peptide) can be synthesized by using existing known methods, or commissioned by a commercial company to synthesize according to the sequence.
[0017] As a preferred technical solution, in step (1), the preparation method of TBI (i.e., 1,1,2,2-tetrakis(4-(1H-benzo[d]imidazol-2-yl)phenyl)ethene) is as follows: 1,1,2,2-tetrakis(4-(1H-benzo[d]imidazol-2-yl)phenyl)ethene, o-phenylenediamine and polyphosphoric acid (PPA, CAS No.: 8017-16-1) are added into a container, and then stirred at 160°C to 200°C for 8h to 12h for reaction; after the reaction is completed, post-treatment is performed to obtain TBI; wherein the molar ratio of 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene to o-phenylenediamine is 1:1 to 1:10.
[0018] As a further preferred technical solution, the post-treatment method is: after cooling to 60°C to 100°C, putting it into ice water, after fully stirring, filtering it with suction, adding the filter cake to a saturated sodium bicarbonate solution and stirring overnight, after the stirring is completed, filtering it with suction, adding the filter cake to pure water and stirring for 8 h to 12 h, after the stirring is completed, filtering it with suction to obtain a filter cake, and recrystallizing the filter cake twice in methanol to obtain a bright yellow solid, namely TBI.
[0019] As a preferred technical solution, in step (1), the concentration of the NaOH aqueous solution is 1.25 mM, so as to ensure that the pH of the assembly is 8. When the pH is 8, the peptide is at the isoelectric point and TBI remains electrically neutral, so that intermolecular hydrogen bonds can be formed between them.
[0020] As a preferred technical solution, in step (2), the microfluidic chip is a laminar flow chip.
[0021] As a preferred technical solution, in step (2), the width and height of the assembly channel of the microfluidic chip are 300 μm and 100 μm respectively. If the chip channel is too small, it is easy to clog the chip, while if the channel is too large, it is similar to the existing vial open system and cannot produce the corresponding technical effect.
[0022] As a preferred technical solution, in step (2), the flow rate of the inner channel of the chip is 1-3 μL / min, and the flow rate of the outer channel of the chip is 4-12 μL / min. The selection of such a flow rate is the result of comprehensive consideration of the liquid holding capacity of the chip and whether a stable laminar flow can be maintained. If the flow rate is too small, a stable laminar flow may not be formed, while if the flow rate is too large, the laminar flow will turn into turbulent flow; in addition, if the flow rate is too large, the advantage of laminar flow, that is, the advantage of uniform and rapid diffusion and collision between the molecules constituting the assembly, will also disappear.
[0023] As a further preferred technical solution, in step (2), a four-channel chip is used, i.e., two channels on the inner side and two channels on the outer side, wherein the flow rate of the inner channel is 2 μL / min, the flow rate of the outer channel is 8 μL / min, and the total flow rate of the microfluidic chip is 20 μL / min. At this flow rate, the laminar flow is more stable and the spiral structure obtained is more uniform.
[0024] The second object of the present invention is to provide a polypeptide-based helical fiber with circularly polarized luminescence prepared by the above method.
[0025] For multi-component assemblies, it is expected that efficient chirality transfer from chiral substances to non-chiral substances can be achieved based on the helical structure, which is crucial for the construction of efficient CPL materials. Different from the self-assembly behavior of molecules in existing open system vials, the present invention uses a microfluidic device to provide a continuous mobile phase at the micrometer level, which can regulate the different molecular interactions at different positions during the flow process. Since the diffusion and mass transfer characteristics of molecules are enhanced in such a microspace, the solvent exchange process and molecular interactions between solute molecules can be carried out very quickly and evenly. In addition, the micrometer-level laminar flow allows the fiber self-assembly structure to align with the laminar flow, thereby producing uniform helical fibers at the micrometer level.
[0026] Compared with the prior art, the advantages of the present invention are as follows: the present invention utilizes the multiple hydrogen bonds between polypeptides, based on the solute conformation restriction and the orderly diffusion mechanism of the solvent in the microfluidic laminar flow chip, to develop a polypeptide-based circularly polarized luminescent material with excellent luminescence performance; the circular dichroism and circular polarization spectrum tests show that the spiral fiber material obtained by the present invention has a mirror-symmetric signal; compared with the material obtained by traditional solution stirring, the polypeptide-based spiral fiber prepared in the microfluidic chip of the present invention not only has a more uniform morphology, but also has a larger g lum The luminescence asymmetry factor of L-peptide / TBI and D-peptide / TBI was ±1.9 × 10 -3 ; This method has a certain degree of universality and is applicable to the assembly of other macromolecules, including polymers, nucleic acids, and proteins. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] Figure 1The structure diagram of the microfluidic chip prepared in Example 1;
[0028] Figure 2 Schematic diagram of each channel of the microfluidic chip;
[0029] Figure 3 The structure diagram of L- / D-Peptide prepared in Example 1;
[0030] Figure 4 This is the H NMR spectrum of TBI prepared in Example 1;
[0031] Figure 5 The NMR carbon spectrum of TBI prepared in Example 1;
[0032] Figure 6 is the mass spectrum of TBI prepared in Example 1;
[0033] Figure 7 The high performance liquid chromatography of the L-Peptide of Example 1;
[0034] Figure 8 is the mass spectrum of L-Peptide in Example 1;
[0035] Fig. 9 The high performance liquid chromatography of D-Peptide in Example 1;
[0036] Fig.10 is the mass spectrum of D-Peptide in Example 1;
[0037] Fig.11 The morphology of the Peptide / TBI assembly in the microfluidic chip of Example 1, wherein a) is a TEM image of L-Peptide / TBI, b) is a TEM image of D-Peptide / TBI, c) is a SEM image of L-Peptide / TBI, and d) is a SEM image of D-Peptide / TBI;
[0038] Fig.12 TEM image of L-Peptide / TBI in the vial of Comparative Example 1;
[0039] Fig.13 a) circularly polarized luminescence and b) luminescence asymmetry factor spectra of the assembly prepared in the microfluidic chip of Example 1;
[0040] Fig.14 a) H NMR spectrum and b) X-ray diffraction spectrum of the assembly of Example 1. DETAILED DESCRIPTION
[0041] The present invention will be further described below in conjunction with the accompanying drawings.
[0042] Embodiment 1:
[0043] A microfluidics-based polypeptide-based helical fiber with circularly polarized luminescence, the preparation method of which comprises the following steps:
[0044] (1) Preparation of TBI: 1,1,2,2-Tetra(4-carboxyphenyl)ethylene, o-phenylenediamine and PPA were added to a 100 mL round-bottom flask and then stirred at 180 °C for 8 h. After the reaction was completed, the mixture was cooled to 80 °C and then put into ice water. After sufficient stirring, the mixture was filtered and the filter cake was added to a saturated sodium bicarbonate solution and stirred overnight. After stirring, the mixture was filtered again and the filter cake was added to pure water and stirred for 8 h. After stirring, the filter cake was filtered and recrystallized twice in methanol to obtain a bright yellow solid, namely TBI. Its H NMR spectrum, C NMR spectrum and mass spectrum are shown in FIG. Figure 4-Figure 6 As shown; wherein, the molar ratio of 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene to o-phenylenediamine is 1:4, and the reaction formula is:
[0045] ;
[0046] (2) L-peptide or D-peptide with the amino acid sequence of GFFVLK (such as Figure 3 As shown in the figure, the L-Peptide and D-Peptide were dissolved in DMSO at a concentration of 8 mM, and the TBI prepared in step (1) was also dissolved in DMSO at a concentration of 2 mM; and a 1.25 mM NaOH aqueous solution was prepared; wherein the HPLC and mass spectra of L-Peptide and D-Peptide are shown in Figure 7-Figure 10 As shown;
[0047] (3) Preparation of spiral fiber assembly in microfluidic chip: The DMSO solution of L-peptide or D-peptide and the DMSO solution of TBI prepared in step (2) flow into the microfluidic laminar flow chip (chip structure as shown in FIG. Figure 1 As shown, it is a four-channel chip; the schematic diagram of each channel is as follows Figure 2 As shown in the figure, the NaOH aqueous solution prepared in step (2) flows into the microfluidic laminar flow chip through the outer channel, and then is assembled in the chip to obtain the L / D Peptide / TBI assembly; wherein the flow rate of the inner channel of the chip is 2 μL / min; the flow rate of the outer channel of the chip is 8 μL / min; and the total flow rate of the chip is 20 μL / min.
[0048] Comparative Example 1
[0049] Use a pipette to take 100 μL of the DMSO solution of the L-peptide or D-peptide with the sequence of GFFVLK obtained in step (2) of Example 1 and 100 μL of the DMSO solution of TBI into a 5 mL vial, shake it slightly and add 800 μL of NaOH aqueous solution (concentration 1.25 mM) to assemble to obtain an assembly, which is then aged in the same manner as in Example 1.
[0050] Test example:
[0051] (1) Morphological characterization of the peptide / TBI assembly in microfluidics of Example 1
[0052] The assembly flowing out of the chip in the above-mentioned Example 1 was collected in a vial and aged for 8 h. The assembly morphology was characterized by transmission electron microscopy (TEM) and scanning electron microscopy (SEM);
[0053] The TEM sample was prepared as follows: first, a copper grid was placed on the filter paper, 20 μL of the aged L / D Peptide / TBI assembly was dropped on the copper grid and dried naturally;
[0054] like Fig.11 As shown in a), L-Peptide / TBI exhibits uniform left-handed helical fibers, proving that L-Peptide and TBI are efficiently co-assembled in the chip thanks to the diffusion and collision of molecules in laminar flow. Moreover, the anti-configuration co-assembly D-Peptide / TBI has helical fibers in the opposite (right-handed) direction ( Fig.11 b)). These results demonstrate that the chirality of the peptide was successfully transferred to the Peptide / TBI co-assembly. Figure 3 "L-Referenece" in the figure), which cannot form a helical structure when co-assembled with TBI, demonstrating the selective assembly properties of different polypeptide structures.
[0055] In order to further characterize the morphology of the assembly, this test example also performed SEM characterization on the assembly. The results are as follows Fig.11 c) and 11d), the SEM results further prove that the present invention successfully utilizes microfluidic laminar flow assembly to obtain uniform spiral fibers.
[0056] (2) Morphological characterization of the assembly obtained in Comparative Example 1
[0057] Since the assembly environment in the vial in Comparative Example 1 is different from that in the microfluidic system in Example 1, different assembly morphologies may be produced. Similarly, the inventors also used the same method to prepare TEM samples after the assembly in the vial in Comparative Example 1 was aged for 8 h. The results are shown in FIG. Fig.12 As shown, unlike the uniform spiral fibers obtained in the microfluidic chip of Example 1, the spiral fibers prepared in the vial of Comparative Example 1 are neither obvious nor uniform. Such results show that the microfluidic laminar flow system has great application prospects in controlling the assembly morphology of the assembly.
[0058] (3) Circularly polarized luminescence property test of the assembly prepared by the microfluidic chip of Example 1
[0059] Since the present invention uses a chiral polypeptide and an achiral aggregation-induced luminescent molecule for co-assembly, it is expected to realize the construction of a circularly polarized luminescent material.
[0060] For verification, the circularly polarized luminescent sample was prepared as follows: the assembly obtained in the microfluidic chip of Example 1 was aged for 8 h, centrifuged, and then evenly coated on a quartz plate;
[0061] Through testing, it was found that L-Peptide / TBI and D-Peptide / TBI have positive and negative circularly polarized luminescence signals, respectively. Fig.13 a); in addition, the luminescence asymmetry factor (g lum ) is often used to evaluate the size of circularly polarized luminescence. The luminescence asymmetry factors of L-Peptide / TBI and D-Peptide / TBI prepared in Example 1 were 1.9 × 10 -3 ,like Fig.13 b), which indicates that the present invention has successfully constructed a circularly polarized luminescent material with a large luminescence asymmetry factor.
[0062] (4) Research and experiment on assembly mechanism
[0063] To investigate the assembly mechanism of peptide and TBI, the inventors performed H NMR spectroscopy ( 1 H NMR) and X-ray diffraction (XRD) characterization:
[0064] The sample preparation for H NMR spectrum is as follows: a certain amount of L-peptide of step (2) of Example 1 and TBI of step (1) of Example 1 are weighed and dissolved in DMSO-d6, and sodium hydroxide is dissolved in H2O-d2, with the concentrations of 8 mM and 2 mM respectively, and the volume ratio of DMSO-d6 to H2O-d2 is 39 / 1;
[0065] The results are as follows Fig.14As shown in a), it can be seen from the figure that H1, H2 and H4 of TBI move significantly to the low field after co-assembly with L-Peptide, while H3 moves slightly to the high field. The changes in the H-NMR spectrum indicate that the driving force of the assembly may be the intermolecular hydrogen bond between L-Peptide and TBI;
[0066] In addition, the results of X-ray diffraction are as follows Fig.14 As shown in b), the figure shows that the peak shape changes significantly before and after assembly, which further confirms the successful assembly of L-Peptide and TBI.
[0067] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A method for preparing a polypeptide-based helical fiber with circularly polarized luminescence based on microfluidics, characterized in that: The method is: (1) First, prepare L -peptide or D - DMSO stock solution of peptide, DMSO stock solution of TBI, and aqueous NaOH solution; (2) Then make the L -peptide or D - The DMSO mother solution of the peptide and the DMSO mother solution of TBI flow into the chip from the inner channel of the microfluidic chip, and the NaOH aqueous solution flows into the chip from the outer channel of the microfluidic chip, and then the assembly is performed in the microfluidic chip to obtain an assembly; (3) Aging the assembly to obtain polypeptide-based helical fibers with circularly polarized luminescence.
2. The method according to claim 1, characterized in that In step (1), the L -peptide or D - The amino acid sequence of the peptide is GFFVLK or KLVFF.
3. The method according to claim 1, characterized in that In step (1), the preparation method of TBI is as follows: 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene, o-phenylenediamine and polyphosphoric acid are added into a container, and then stirred at 160°C to 200°C for 8 h to 12 h for reaction; after the reaction is completed, post-treatment is performed to obtain TBI; wherein the molar ratio of 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene to o-phenylenediamine is 1:1 to 1:
10.
4. The method according to claim 3, characterized in that: The post-treatment method is as follows: after cooling to 60-100° C., the mixture is put into ice water, and after being fully stirred, suction filtration is performed, the filter cake is added into a saturated sodium bicarbonate solution and stirred overnight, and after the stirring is completed, suction filtration is performed again, the filter cake is added into pure water and stirred for 8-12 hours, and after the stirring is completed, suction filtration is performed to obtain a filter cake, and the filter cake is recrystallized twice in methanol to obtain a bright yellow solid, namely TBI.
5. The method according to claim 1, characterized in that: In step (1), the concentration of the NaOH aqueous solution is 1.25 mM.
6. The method according to claim 1, characterized in that In step (2), the microfluidic chip is a laminar flow chip.
7. The method according to claim 1, characterized in that In step (2), the width and height of the assembly channel of the microfluidic chip are 300 μm and 100 μm, respectively.
8. The method according to claim 1, characterized in that In step (2), the flow rate of the inner channel of the chip is 1 to 3 μL / min; the flow rate of the outer channel of the chip is 4 to 12 μL / min.
9. The method according to claim 1, characterized in that: In step (2), the total flow rate of the microfluidic chip is 20 μL / min.
10. A polypeptide-based helical fiber having circularly polarized luminescence prepared by the method according to any one of claims 1 to 9.
Citation Information
Patent Citations
Fluorescent dipeptide molecule self-assembly body and application thereof in circularly polarized light emission
CN115505027A
Microfluidic preparation method of self-assembled polypeptide microspheres
CN115554249A
circular polarizer
FR1334543A
Polypeptide helix, polypeptide material using the same, its production and use of polypeptide material
JP1998087694A
